US Drug Recall Register
Class III · Low risk Terminated Initiated Jul 2, 2012 (14 years ago)

Carboplatin Injection, 10 mg/mL, a) 5 mL multi-dose vials (NDC 61703-339-18) (NDC…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed PH specification: The lots of Carboplatin Injection were manufactured from Carboplatin API lots which trended out of specification low pH.

What was recalled

Carboplatin Injection, 10 mg/mL, a) 5 mL multi-dose vials (NDC 61703-339-18) (NDC 61703-360-18, NOVAPLUS), b) 45 mL multi-dose vials (NDC 61703-339-50) (NDC 61703-360-50 NOVAPLUS), Rx only, Hospira, Inc., Lake Forest, IL 60045, Product of Australia

Recalling firm
Hospira Inc.
NDC code
61703-339-18
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1648-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Carboplatin recalls

See all